Early vs. late administration of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention of acute ST-segment elevation myocardial infarction

Article Abstract:

Primary percutaneous coronary intervention (PCI) has always been the reperfusion strategy in ST-segment elevation myocardial infarction (STEMI) and meta-analysis of trials of early vs. late intravenous administration of Gp IIb/IIIa inhibitors in STEMI was done. In 6 meta-analysis early administration of inhibitors in STEMI helped improve coronary patency with positive trends for clinical outcomes, but further evaluations are suggested.

Glycoproteins

---

Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction

Article Abstract:

The study conducted determines whether protection of the distal microcirculation from throm-boembolic debris liberated during primary percutaneous coronary intervention (PCI) results in improved reperfusion and decreased infract size. The result reveals that a distal balloon occlusion and aspiration system effectively retrieves embolic debris in most patients with acute segment elevation myocardial infarction undergoing emergent PCI.

Risk factors, Microcirculation disorders

---

Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction

Article Abstract:

A study was conducted to assess the value of stem cell mobilization by Granulocyte Colony Stimulating Factor (G-CSF) therapy in patients with acute Myocardial Infarction (MI). The results showed that stem cell mobilization by G-CSF therapy in patients with acute MI and successful mechanical reperfusion has no influence on infarct size, left ventricular function, or coronary restenosis.

Granulocytes, Granulocyte colony-stimulating factor, Cellular therapy, Cell therapy

Similar abstracts:

• Abstracts: Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction
• Abstracts: Management of patients undergoing percutaneous coronary revascularization. Management of patients undergoing percutaneous coronary interventions
• Abstracts: Expression and regulation of luteinizing hormone/human chorionic gonadotropin receptors in ovarian cancer and its correlation to human chorionic gonadotropin-doxorubicin sensitivity
• Abstracts: Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival
• Abstracts: Oral antiplatelet therapy in cerebrovascular disease, Coronary artery disease, and peripheral arterial disease

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.